Su Yin

[Expert Profile] Su Yin, Chief Physician, Professor, Doctoral Supervisor, is an authoritative expert in the intersection of rheumatology and hematological immunology in China, working in the Department of Rheumatology, Peking University People's Hospital. She has long been dedicated to the clinical diagnosis, treatment, and scientific research of immune-related hematological diseases such as immune thrombocytopenia and thrombotic thrombocytopenic purpura, and is an important expert in rheumatology in China.

[Education & Career] Professor Su Yin graduated from Beijing Medical University (now Peking University Health Science Center), completed systematic clinical training at Peking University People's Hospital, and has long been engaged in clinical, teaching, and research work in rheumatology. She has held academic positions including standing committee member of the Rheumatology Branch of the Chinese Medical Association, and has presided over national-level projects including the National Natural Science Foundation of China, accumulating extensive clinical and research experience in immune-related hematological diseases and difficult rheumatology.

[Areas of Expertise] Professor Su specializes in the diagnosis and treatment of immune thrombocytopenia (ITP), thrombotic thrombocytopenic purpura (TTP), systemic lupus erythematosus with hematological involvement, antiphospholipid syndrome, and various difficult rheumatic diseases. She is proficient in differential diagnosis and comprehensive treatment of immune-mediated cytopenias, and excels at managing complex cases of rheumatic diseases complicated with thrombocytopenia, anemia, and thrombosis, helping numerous patients identify the immunological causes behind blood abnormalities and develop individualized regimens balancing hematology and immunology.

[Academic Achievements & Industry Contributions] Professor Su has led a series of clinical studies on immune-related hematological diseases and rheumatology, systematically evaluating treatment strategies and prognostic factors for conditions such as ITP and TTP, with findings published in authoritative domestic and international journals. She has participated in the development of Chinese rheumatology and immune hematology diagnosis and treatment guidelines, promoted standardized diagnosis and treatment of immune-related hematological diseases, and organized exploration of multidisciplinary collaborative (rheumatology + hematology) diagnosis models, making important contributions to improving the care standards for these interdisciplinary difficult conditions.

[Clinical Practice & Outstanding Contributions] Professor Su has long held expert rheumatology clinics, cumulatively treating tens of thousands of patients with immune-related hematological diseases and various rheumatic conditions, providing immunological diagnoses for numerous patients with "recurrently low platelets of unknown origin." She is patient and meticulous with patients, values thorough doctor-patient communication, and is deeply trusted by patients. She has been invited to deliver reports at national academic conferences on multiple occasions, trained a large number of rheumatology professionals, and is a rheumatology expert recognized by peers alike.

[Honors & Reputation] Professor Su Yin serves as Director of the Rheumatology Department at Peking University People's Hospital, among other academic positions. She has presided over grants from the National Natural Science Foundation of China and major provincial and ministerial projects, and is a senior expert in the field of rheumatology in China. She has profound expertise in the diagnosis and treatment of rheumatic immune-related blood abnormalities such as immune thrombocytopenia and thrombotic thrombocytopenic purpura. She has led research on standardized diagnosis and treatment of rheumatic diseases with hematological involvement, promoted multidisciplinary collaboration and critical care system development, and participated in the development of multiple rheumatology diagnosis and treatment guidelines. For decades on the clinical front lines, she has helped numerous difficult rheumatology patients identify their disease causes and receive standardized treatment, and is deeply trusted by patients and respected by peers alike.